248 related articles for article (PubMed ID: 31907122)
21. Combined application of pharamcokinetic DCE-MRI and IVIM-DWI could improve detection efficiency in early diagnosis of ductal carcinoma in situ.
Tao WJ; Zhang HX; Zhang LM; Gao F; Huang W; Liu Y; Zhu Y; Bai GJ
J Appl Clin Med Phys; 2019 Jul; 20(7):142-150. PubMed ID: 31124276
[TBL] [Abstract][Full Text] [Related]
22. Association of DW/DCE-MRI features with prognostic factors in breast cancer.
Shao G; Fan L; Zhang J; Dai G; Xie T
Int J Biol Markers; 2017 Mar; 32(1):e118-e125. PubMed ID: 27646773
[TBL] [Abstract][Full Text] [Related]
23. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
24. Dynamic contrast-enhanced magnetic resonance imaging features and apparent diffusion coefficient value of HER2-positive/HR-negative breast carcinoma.
Chen P; Zhao S; Guo W; Shao G
Quant Imaging Med Surg; 2023 Aug; 13(8):4816-4825. PubMed ID: 37581065
[TBL] [Abstract][Full Text] [Related]
25. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.
Santamaría G; Velasco M; Farrús B; Caparrós FX; Fernández PL
Breast J; 2013; 19(4):402-10. PubMed ID: 23758454
[TBL] [Abstract][Full Text] [Related]
26. Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement.
Cheng L; Bai Y; Zhang J; Liu M; Li X; Zhang A; Zhang X; Ma L
Tumour Biol; 2013 Jun; 34(3):1537-45. PubMed ID: 23397543
[TBL] [Abstract][Full Text] [Related]
27. Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.
Mori N; Ota H; Mugikura S; Takasawa C; Tominaga J; Ishida T; Watanabe M; Takase K; Takahashi S
Eur Radiol; 2013 Oct; 23(10):2705-12. PubMed ID: 23732688
[TBL] [Abstract][Full Text] [Related]
28. Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer.
Knuttel FM; van der Velden BH; Loo CE; Elias SG; Wesseling J; van den Bosch MA; Gilhuijs KG
Invest Radiol; 2016 Jul; 51(7):462-8. PubMed ID: 26863579
[TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
Choi EJ; Youk JH; Choi H; Song JS
J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
[TBL] [Abstract][Full Text] [Related]
30. Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ.
Yoon HJ; Kim Y; Kim BS
Eur Radiol; 2015 Dec; 25(12):3648-58. PubMed ID: 26063655
[TBL] [Abstract][Full Text] [Related]
31. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.
Mori N; Abe H; Mugikura S; Miyashita M; Mori Y; Oguma Y; Hirasawa M; Sato S; Takase K
Breast Cancer; 2021 Sep; 28(5):1141-1153. PubMed ID: 33900583
[TBL] [Abstract][Full Text] [Related]
32. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Br J Radiol; 2017 Nov; 90(1079):20170394. PubMed ID: 28876982
[TBL] [Abstract][Full Text] [Related]
33. [3.0 T MR diffusion tentor imaging in the differential diagnosis of breast mass lesions].
Si LF; Liu XJ; Yang KY; Wang L; Jiang T
Zhonghua Yi Xue Za Zhi; 2016 May; 96(19):1510-4. PubMed ID: 27266497
[TBL] [Abstract][Full Text] [Related]
34. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
35. Apparent diffusion coefficient value of diffusion-weighted imaging for differential diagnosis of ductal carcinoma in situ and infiltrating ductal carcinoma.
Ding JR; Wang DN; Pan JL
J Cancer Res Ther; 2016; 12(2):744-50. PubMed ID: 27461644
[TBL] [Abstract][Full Text] [Related]
36. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
37. Triexponential Diffusion Analysis of Diffusion-weighted Imaging for Breast Ductal Carcinoma in Situ and Invasive Ductal Carcinoma.
Ohno M; Ohno N; Miyati T; Kawashima H; Kozaka K; Matsuura Y; Gabata T; Kobayashi S
Magn Reson Med Sci; 2021 Dec; 20(4):396-403. PubMed ID: 33563872
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
39. [Correlations between MRI apparent diffusion coefficient and histological grade and molecular biology of breast invasive ductal carcinoma].
Yu X; Liu S; Chen Z; Zhang P; Zhang J; Xu L; Liu Z; Ren R
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):606-11. PubMed ID: 25430028
[TBL] [Abstract][Full Text] [Related]
40. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
Lee SA; Lee Y; Ryu HS; Jang MJ; Moon WK; Moon HG; Lee SH
Radiology; 2022 Nov; 305(2):307-316. PubMed ID: 35787199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
